Tag: Lysogene
Lysogene: The American Sarepta and Lysogene end their partnership around a gene therapy
(BFM Bourse) – A few months before the announcement of the results of a decisive clinical study, the American biotech company Sarepta and Lysogene have terminated a license agreement which…
Lysogene: termination of license agreements with Sarepta
(CercleFinance.com) – Lysogene sells nearly 3% on Thursday on the Paris Bourse after the announcement of the termination of the licensing agreements signed with Sarepta for the LYS-SAF302 program, an…
Lysogene: Loan agreement with the EIB
Receive free of charge each morning the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM…
Lysogene: loan of 15 million euros from the European Investment Bank – 12/24/2021 at 08:44
(AOF) – Lysogene has entered into a € 15 million loan agreement with the European Investment Bank to accelerate the development of its gene therapy platform. This funding will support…
Lysogene: loan agreement with the EIB – 12/24/2021 at 09:50
(CercleFinance.com) – The biopharmaceutical company Lysogene announces that it has entered into a € 15 million loan agreement with the European Investment Bank (EIB) to accelerate the development of its…
Lysogene receives a European loan of 15 million euros
The biopharmaceutical company has signed a loan agreement with the European Investment Bank. The funds will allow Lysogene to finance its work, in particular in the treatment of Landing’s disease…
Lysogene receives MHRA UK Innovation Passport for its gangliosidosis program at GM1 – 12/20/2021 at 08:00
To receive all of Lysogene’s financial information in real time, send a request by email to [email protected] This approach is part of the recent initiative of the British MHRA to…